Treatment of S. typhimurium-infected mice with the TREM-1 inhibitor LP17 was advantageous for ameliorating SpvB-mediated hepatic inflammation and, therefore, iron metabolic disorder (Figure 8). Here, TREM1 is linked to metabolic disease.